Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.70m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Proposed Director Dealing

30 Sep 2020 13:30

RNS Number : 6272A
Science Group PLC
30 September 2020
 

 

 

 

30 September 2020

 

Science Group plc

(the "Company" or "Science Group")

 

 

Proposed Director Dealing

 

Science Group announces that it has been notified by Martyn Ratcliffe, Executive Chairman of the Company of his intention to sell up to 2,000,826 ordinary shares of £0.01 each in the Company ("Sale Shares") at a price of 240 pence per Sale Share (the "Sale").

The Sale Shares represent approximately 4.8% of the Company's issued share capital excluding treasury shares. Assuming all the Sale Shares are sold, Martyn Ratcliffe will, following completion of the Sale, continue to have an interest in approximately 27.25% of the issued share capital (excluding treasury shares) of the Company.

Martyn Ratcliffe has undertaken that he will not dispose of any further ordinary shares for a period of 12 months after completion of the Sale (subject to customary exceptions).

The Company is not a party to the Sale and will not receive any proceeds from the Sale.

Background to the Transaction

In January 2019, at the conclusion of the strategic review, the Board of Science Group highlighted that while "the Company benefits from a supportive shareholder base, the lack of liquidity creates a market inefficiency which may impact the valuation of the Group."

Since 2010, the largest shareholder in the Company has been the Executive Chairman, Martyn Ratcliffe, following his investment in March of that year and the subsequent placing in May 2010. Mr Ratcliffe's current shareholding is 13,412,906 shares equivalent to 32.03% of the issued share capital excluding treasury shares. Due to the scale of Mr Ratcliffe's shareholding, each year shareholders and the Takeover Panel must also approve a waiver of Rule 9 of the Takeover Code in order that the Company can undertake share buy-backs.

Mr Ratcliffe has now agreed to reduce his shareholding in order to broaden the shareholder base and reduce shareholder concentration through the Sale. Following this transaction, Mr Ratcliffe will remain the Group's largest shareholder.

 

End

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

www.sciencegroup.com

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

MHP Communications (PR Advisor to Science Group)

Reg Hoare, James Bavister, Pete Lambie

Tel: +44 (0) 20 3128 8100

sciencegroup@mhpc.com

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Sarah Cole, Company Secretary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKKBDBBKDCCN
Date   Source Headline
9th Mar 20217:00 amRNSAudited results for year ended 31 December 2020
4th Mar 20215:00 pmRNSTR1: Notification of Major Interest in Shares
11th Jan 20217:00 amRNSTrading, Business and Board Update
8th Jan 20214:40 pmRNSTR1: Notification of Major Interest in Shares
2nd Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSTransaction in Own Shares
23rd Nov 20207:00 amRNSTransaction in Own Shares
20th Nov 20207:00 amRNSTransaction in Own Shares
18th Nov 20205:00 pmRNSTR1: Notification of Major Interest in Shares
16th Nov 202010:46 amRNSTransaction in Own Shares
16th Nov 202010:45 amRNSTransaction in Own Shares
16th Nov 20207:00 amRNSTransaction in Own Shares
13th Nov 20207:00 amRNSTransaction in Own Shares
11th Nov 20207:00 amRNSPDMR dealing
12th Oct 20207:00 amRNSTrading Update
8th Oct 20207:00 amRNSIssue of share options & PDMR dealing
5th Oct 20207:00 amRNSTR1: Notification of Major Interest in Shares
1st Oct 202011:15 amRNSTR1: Notification of Major Interest in Shares
30th Sep 20202:30 pmRNSDirector Dealing & Exercise of Share Options
30th Sep 20201:30 pmRNSProposed Director Dealing
10th Sep 20207:00 amRNSTrading and Dividend Update
28th Jul 20207:00 amRNSInterim Results for six month period ended 30/6/20
17th Jun 20207:01 amRNSBoard Appointment
17th Jun 20207:00 amRNSNominated Adviser and Joint Broker
16th Jun 202012:15 pmRNSResult of Annual General Meeting
16th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20207:01 amRNSTR1: Notification of Major Interest in Shares
9th Jun 20207:00 amRNSTransaction in Own Shares
8th Jun 20207:00 amRNSTransaction in Own Shares
5th Jun 20207:00 amRNSTransaction in Own Shares
4th Jun 20207:00 amRNSTransaction in Own Shares
29th May 20207:00 amRNSTop Up of Bank Loan
22nd May 20207:00 amRNSTransaction in Own Shares
18th May 20207:00 amRNSTransaction in Own Shares
15th May 20207:00 amRNSPosting of AGM documents and Director Changes
11th May 20207:00 amRNSAGM Update, Capital Allocation and Dividend Policy
7th May 20204:50 pmRNSChange of auditors
7th May 20207:00 amRNSTransaction in Own Shares
6th May 20207:00 amRNSTransaction in Own Shares
4th May 20207:00 amRNSVentilator Programme, Trading & Financial Update
2nd Apr 20204:00 pmRNSTR1: Notification of Major Interest in Shares
2nd Apr 20201:30 pmRNSTR1: Notification of Major Interest in Shares
31st Mar 20201:46 pmRNSTrading Update, AGM and Covid-19
31st Mar 20201:45 pmRNSUK Government Ventilator Programme
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSAudited results for year ended 31 December 2019
6th Jan 20207:00 amRNSAppointment of Joint Broker
29th Nov 20197:00 amRNSTreasury shares issued
27th Nov 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.